Contact this trialFirst, we need to learn more about you.
Coagulation Factor
BAX855 for Severe Hemophilia A
Recruiting2 awardsPhase 3
Houston, Texas
This trial is for young children with severe hemophilia A who have not been treated with BAX855 or other FVIII concentrates. The goal is to check for side effects and learn how well BAX855 controls bleeding.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service